Success Stories: A Remarkable NIW Approval for a Principal Biomarker Statistician from China Secured in Just 1 Month, 23 Days Through Our Dedicated Efforts
Client’s Testimonial:
“I am very satisfied with the whole process regarding quality and speed. Also, I feel the lawyer team sincerely tries to advocate for my case, which I appreciate.”
On March 4th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Principal Biomarker Statistician in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Principal Biomarker Statistician
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: March 4th, 2025
Processing Time: 1 month, 23 days (Premium Processing Requested)
Case Summary:
At our firm, we prioritize I-140 clients and employ a strategic approach to maximize their chances of approval. By carefully analyzing each case, we highlight its unique strengths to strengthen the petition.
When a principal biomarker statistician from China approached the North America Immigration Law Group for assistance with an NIW (National Interest Waiver) petition, we thoroughly evaluated her research. We determined that her work holds significant value, particularly for U.S. technological leadership.
We emphasized her Ph.D. in bioinformatics and its relevance to advancing this industry. Our petition included a comprehensive assessment of her education, expertise, and accomplishments, along with a detailed plan outlining her proposed contributions, progress toward her goals, and the interests of key stakeholders.
Key highlights of her petition included:
- At the time of filing, she had published 5 peer-reviewed journal articles (2 of them first-authored), 1 co-first-authored peer-reviewed conference article, and 3 abstracts (1 of them first-authored).
- Her research has been recognized by leading experts and has inspired fellow researchers in her field. Her work has been cited 62 times, demonstrating its influence in the field.
- As an expert in the field of bioinformatics, her proposed endeavor is to continue her research on developing and applying advanced statistical and machine learning models for analyzing multi-omics data to advance the development of mRNA cancer immunotherapies for treating melanoma, non-small cell lung cancer, and other solid cancers.
- Her study has received funding from the National Institutes of Health (NIH). This funding supports projects that reduce illness and disability. Therefore, her research aligns with the NIH’s goals by advancing the understanding of leiomyoma mechanisms, specifically through characterizing the role of DNA methylation and its therapeutic value.
- She has even received 3 letters of recommendation from fellow experts in the field. Out of those, one of the excerpts is mentioned below:
“It is clear that [client] stands at the top of her field, as evidenced by her achievements, including the advancement of the understanding of DNA methylation and gene regulation. Her work advances research in related areas such as epigenetics and precision medicine, enhancing clinical decision-making and practices that uphold the USA’s leadership position. Ensuring the continuation of [client’s] work is thus deeply important to both bioinformatics research and to the nation.”
Thus, our client has provided independent researchers from around the world with useful approaches to the study of complex topics within the field of bioinformatics. That other researchers consistently look to her methods and findings to inform and guide their studies indicates that she is well positioned to make further useful discoveries in the field of bioinformatics.
We are pleased to share that her petition was approved in 1 month and 23 days. This success underscores our commitment to providing tailored support for every client. We appreciate the USCIS premium processing service, which expedited the adjudication process. We sincerely congratulate our client on this significant achievement and wish her continued success in her future endeavors.

